Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3151
Lantern Pharma
LTRN
$36.1M
| $187K | ﹤0.01% |
43,800
+5,700
| +15% | +$20.1K |
|
|
MAGN
3152
Magnera Corp
MAGN
$421M
| $187K | ﹤0.01% |
7,408
+2,646
| +56% | +$55.7K |
|
3153
authID Inc
AUID
$11.9M
| $186K | ﹤0.01% |
+19,628
| New | +$154K |
|
3154
Caribou Biosciences
CRBU
$163M
| $186K | ﹤0.01% |
+32,400
| New | +$160K |
|
|
PROF
3155
Profound Medical
PROF
$270M
| $186K | ﹤0.01% |
+21,900
| New | +$208K |
|
3156
Rockwell Medical
RMTI
$28.3M
| $186K | ﹤0.01% |
9,820
+8,416
| +599% | +$158K |
|
|
VWE
3157
DELISTED
Vintage Wine Estates, Inc. Common Stock
VWE
| $186K | ﹤0.01% |
369,400
+351,500
| +1,964% | +$200K |
|
|
CMLS
3158
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $183K | ﹤0.01% |
34,400
+13,100
| +62% | +$66.2K |
|
3159
Beasley Broadcasting Group
BBGI
$39.8M
| $182K | ﹤0.01% |
10,356
+1,408
| +16% | +$21.9K |
|
3160
Skillful Craftsman
EDTK
$14.6M
| $182K | ﹤0.01% |
144,200
-8,400
| -6% | -$8.07K |
|
|
STLN
3161
Starling Oncology, Inc. Common Stock
STLN
$682M
| $182K | ﹤0.01% |
89,300
+17,000
| +24% | +$29.5K |
|
3162
United Maritime
USEA
$25.8M
| $182K | ﹤0.01% |
73,616
+43,616
| +145% | +$104K |
|
3163
Pro-Dex
PDEX
$213M
| $181K | ﹤0.01% |
+10,340
| New | +$173K |
|
3164
VanEck Preferred Securities ex Financials ETF
PFXF
$2.45B
| $181K | ﹤0.01% |
+10,522
| New | +$174K |
|
3165
WidePoint Corp
WYY
$108M
| $180K | ﹤0.01% |
77,750
+47,850
| +160% | +$86.1K |
|
|
GPMT
3166
Granite Point Mortgage Trust
GPMT
$59.3M
| $179K | ﹤0.01% |
30,120
-134,980
| -82% | -$680K |
|
3167
a.k.a. Brands
AKA
$118M
| $178K | ﹤0.01% |
22,094
+4,219
| +24% | +$32.6K |
|
3168
Genius Sports
GENI
$2.15B
| $178K | ﹤0.01% |
28,800
-592,300
| -95% | -$3.19M |
|
|
ICD
3169
DELISTED
Independence Contract Drilling, Inc.
ICD
| $178K | ﹤0.01% |
72,800
-1,178
| -2% | -$3.03K |
|
3170
Forafric Global
AFRI
$284M
| $176K | ﹤0.01% |
+16,600
| New | +$184K |
|
3171
Idaho Strategic Resources
IDR
$538M
| $176K | ﹤0.01% |
+27,800
| New | +$154K |
|
3172
Magyar Bancorp
MGYR
$123M
| $176K | ﹤0.01% |
15,700
+3,000
| +24% | +$29.6K |
|
3173
OPAL Fuels
OPAL
$72.3M
| $176K | ﹤0.01% |
+31,800
| New | +$196K |
|
3174
OptimumBank Holdings
OPHC
$106M
| $176K | ﹤0.01% |
42,060
+560
| +1% | +$1.9K |
|
|
NAK
3175
Northern Dynasty Minerals
NAK
$941M
| $175K | ﹤0.01% |
541,206
+120,326
| +29% | +$40K |
|
Similar funds
Renaissance Technologies's Q4 2023 Portfolio in Review
As of Q4 2023, Renaissance Technologies held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Renaissance Technologies's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Renaissance Technologies fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Renaissance Technologies's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Renaissance Technologies opened 702 new positions and closed 633 in Q4 2023.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.